Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (231-240 of 451) with videos related to

Pageof 46
Sort By:
Journal of Neuro-Oncology|October 7, 2020
Response to trametinib treatment in progressive pediatric low-grade glioma patientsFlorian Selt, Cornelis M van Tilburg, Brigitte Bison, et al.
Acta Neuropathologica|April 9, 2018
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrenceLeah M Katz, Thomas Hielscher, Benjamin Liechty, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 14, 2017
Tweety-Homolog 1 Drives Brain Colonization of GliomasErik Jung, Matthias Osswald, Jonas Blaes, et al.
The New England Journal of Medicine|September 21, 2023
Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 MutationsEric Bouffet, Jordan R Hansford, Maria Luisa Garrè, et al.
Neuro-Oncology|May 13, 2020
Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trialMarianne Schell, Irada Pflüger, Gianluca Brugnara, et al.
Acta Neuropathologica|September 7, 2022
Epigenetic profiling reveals a subset of pediatric-type glioneuronal tumors characterized by oncogenic gene fusions involving several targetable kinasesPhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Neuro-Oncology|July 7, 2021
A novel patient stratification strategy to enhance the therapeutic efficacy of dasatinib in glioblastomaObada T Alhalabi, Michael N C Fletcher, Thomas Hielscher, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 29, 2022
DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosisDenise Bernhardt, Laila König, Anca Grosu, et al.
Neuro-Oncology|January 12, 2023
EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selectionDavid Capper, Guido Reifenberger, Pim J French, et al.
Neuro-Oncology|November 23, 2017
Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot studyElke Pfaff, Tobias Kessler, Gnana Prakash Balasubramanian, et al.
Pageof 46

Showing results (231-240 of 451) with videos related to

Sort By:
Pageof 46
Journal of Neuro-Oncology|October 7, 2020
Response to trametinib treatment in progressive pediatric low-grade glioma patientsFlorian Selt, Cornelis M van Tilburg, Brigitte Bison, et al.
Acta Neuropathologica|April 9, 2018
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrenceLeah M Katz, Thomas Hielscher, Benjamin Liechty, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 14, 2017
Tweety-Homolog 1 Drives Brain Colonization of GliomasErik Jung, Matthias Osswald, Jonas Blaes, et al.
The New England Journal of Medicine|September 21, 2023
Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 MutationsEric Bouffet, Jordan R Hansford, Maria Luisa Garrè, et al.
Neuro-Oncology|May 13, 2020
Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trialMarianne Schell, Irada Pflüger, Gianluca Brugnara, et al.
Acta Neuropathologica|September 7, 2022
Epigenetic profiling reveals a subset of pediatric-type glioneuronal tumors characterized by oncogenic gene fusions involving several targetable kinasesPhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Neuro-Oncology|July 7, 2021
A novel patient stratification strategy to enhance the therapeutic efficacy of dasatinib in glioblastomaObada T Alhalabi, Michael N C Fletcher, Thomas Hielscher, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 29, 2022
DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosisDenise Bernhardt, Laila König, Anca Grosu, et al.
Neuro-Oncology|January 12, 2023
EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selectionDavid Capper, Guido Reifenberger, Pim J French, et al.
Neuro-Oncology|November 23, 2017
Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot studyElke Pfaff, Tobias Kessler, Gnana Prakash Balasubramanian, et al.
Pageof 46